Optimising outcomes in patients with VTE
VTE is a collective term for both DVT and PE. With an estimated incidence rate of 1-2 per 1,000 of the population in the UK, VTE is a significant cause of mortality and disability in England with thousands of deaths directly attributed to it each year. One in twenty people will have VTE during their lifetime (reference: http://apptg.org.uk/).
VTE poses a significant burden on the NHS with an estimated annual cost of £ 146.7 million (reference: http://apptg.org.uk/wp-content/uploads/APPTG-annual-survey-report-2018-compressed.pdf).
At this patient case-based webinar, you will have the opportunity to look at practical implementation of relevant guidelines to optimise outcomes in patients with VTE.
This webinar covers practical guidance on the management and treatment of patients with acute VTE. It further covers the risk of VTE recurrence to understand which patient may benefit from extented anticoagulation, as well as the secondary prevention of VTE in patients with CAT.
In response to pressures on the NHS, the way health care professionals deliver anticoagulants may need to change. NHS England has recently published a clinical guide for the management of anticoagulant services during the coronavirus pandemic
Royal Pharmaceutical Society (RPS) guidance
The clinical guide states transitioning appropriate patients from warfarin to a DOAC may be considered to avoid regular blood tests for INR monitoring. Whilst DOACs require blood tests to assess hepatic/renal function throughout treatment - the monitoring is predictable, less rigorous than INR testing with warfarin and is routinely carried out in primary care.
This programme will be led by Professor Ahmet Fuat and Professor Terry McCormack
Professor Ahmet Fuat Professor Ahmet Fuat was a GP in Darlington, County Durham for 37 years, serving as CVD and Research Lead for the Darlington Primary Care Network and GP Federation. He became Medical Director at Oberoi Consulting in 2023 and will soon begin an Honorary Consultant Lipidologist/GPSI role with the diabetes and endocrinology team at County Durham and Darlington Foundation Trust.
A GPSI in Cardiology for over 25 years, he gained a Postgraduate Diploma in Cardiology from Bradford University with distinction and later tutored on the programme, teaching in heart failure (HF), valve disease, atrial fibrillation and ischaemic heart disease. In 2002, he helped establish the UK’s first one-stop diagnostic and integrated HF clinic. His PhD in HF diagnosis and management, including work on natriuretic peptides, produced influential publications and led to an Honorary Professorship at Durham University. He has contributed to NICE and ESC cardiovascular guidelines and the RCGP CKD/AKI toolkit.
Professor Fuat is the immediate past President of the Primary Care Cardiovascular Society (PCCS), now its Education and Research Lead, and serves as Lipid and HF Primary Care Lead for the North East and North Cumbria Academic Health Science Network. He is a member of the NHSE CVD Prevention Clinical Leadership Group and expert advisory groups for HF and heart valve disease, and a founder member of CaReMe UK.
Committed to medical education, he lectures widely, serves on editorial boards, and reviews for major cardiovascular journals. His contributions to community cardiology have been recognised with Fellowships from the RCGP, RCP London, RCP Edinburgh and the PCCS. At Oberoi, he oversees clinical development of digital disease-management platforms and mentors HF specialist nurses and clinical pharmacists.
Professor Terry McCormack Terry McCormack is the 22nd President of the British and Irish Hypertension Society and the first GP to hold this position. As a GP in Whitby, he set up a research unit which was successful in studies involving hypertension, lipids, anticoagulation and dermatology. For over 25 years he was also a Hospital Practitioner in Anaesthetics. He has over 100 publications to his name and as a result was appointed an honorary Professor of Primary Care Cardiovascular Medicine at Hull York Medical School (HYMS).
Guideline work includes the NICE Hypertension CG127 and NG138, Perioperative Care and Venous Thromboembolism guideline committees. His major achievement was the 2016 AAGBI/BHS preoperative blood pressure guideline. This guideline has more citations than any other in the history of the journal Anaesthesia, the leading anaesthetic journal in the World.
Awards include the 2016 NIHR Leading Commercial Trial Investigator, 2020 HYMS Undergraduate Medicine Teacher of Excellence Award, the RNLI Gold Badge 2016 and RNLI Long Service Medal 2023. He was appointed a Fellow of the European Society of Cardiology as a leading cardiovascular scientist. Together with Henry Purcell and Kim Fox, he edits the British Journal of Cardiology.
This webinar will NOT be recorded due to the presentation being the Intellectual Property of the speakers.
The Zoom link to join the event will be emailed to the email address you booked with. This may be received into your spam/junk inboxes, please check.
If you cannot locate the Zoom link, please email webinar@mediconf.co.uk for assistance.
We no longer offer the option to dial in using your phone due to the excessive fees charged.
Find us on LINKEDIN
© Copyright 2007 - 2026 MediConf ©, Inc. All Rights Reserved ©
Registered Office: MediConf Uk c/o LCW Consulting, SWP, Suffolk House, George Street, Croydon, Surrey, CR0 0YN
Registered in England No. 09705397. Company registered in England and Wales. VAT Registration Number: 219014242
Telephone: 01444 414 264
Website design & development by Dual Media Ltd
This site is intended for use by UK healthcare professionals.
Please select the appropriate option below.